12 Health Care Stocks Moving In Monday's Pre-Market Session

Gainers

  • Cidara Therapeutics CDTX shares rose 14.6% to $0.64 during Monday's pre-market session. The market value of their outstanding shares is at $44.9 million. The company's, Q3 earnings came out 2 days ago.
  • Benitec Biopharma BNTC stock rose 9.99% to $0.19. The company's market cap stands at $4.8 million.
  • DermTech DMTK stock moved upwards by 9.03% to $1.81. The market value of their outstanding shares is at $54.3 million. As per the press release, Q3 earnings came out 2 days ago.
  • Sesen Bio SESN shares increased by 8.81% to $0.59. The company's market cap stands at $118.9 million.
  • Nexalin Technology NXL stock moved upwards by 8.07% to $1.74. The company's market cap stands at $12.6 million.
  • Athenex ATNX stock rose 7.58% to $0.21. The company's market cap stands at $32.9 million. The company's, Q3 earnings came out 2 days ago.

Losers

  • Verve Therapeutics VERV shares decreased by 13.9% to $26.93 during Monday's pre-market session. The market value of their outstanding shares is at $1.6 billion.
  • Nutex Health NUTX stock declined by 8.49% to $0.72. The market value of their outstanding shares is at $469.1 million.
  • Cabaletta Bio CABA shares decreased by 6.67% to $2.1. The market value of their outstanding shares is at $60.9 million.
  • Gelesis Holdings GLS shares declined by 6.66% to $0.24. The company's market cap stands at $17.5 million.
  • Bone Biologics BBLG shares declined by 6.43% to $0.34. The company's market cap stands at $4.8 million.
  • Verastem VSTM shares fell 5.11% to $0.37. The market value of their outstanding shares is at $77.7 million. As per the news, the Q3 earnings report came out 2 days ago. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: MoversBZI-TFM
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!